Empowering Fungal Cell Factories for the Global Bioeconomy. Aspergillus niger is a cornerstone of industrial biotechnology, renowned for its unparalleled capacity to secrete organic acids and proteins. However, achieving theoretical maximum yields requires more than just standard cultivation; it demands the surgical rewiring of complex metabolic networks. CD Biosynsis provides professional Aspergillus niger Genome Editing & Metabolic Engineering Solutions, combining advanced CRISPR-Cas9 RNP (Ribonucleoprotein) technology with sophisticated metabolic flux analysis to create high-performance strains tailored for sustainable production.
Get a Technical QuoteOur integrated platform addresses the biological bottlenecks of filamentous fungi, offering a clear path from wild-type isolates to optimized industrial chassis through precision engineering and metabolic redirection.
| Service Category | Technical Focus | Primary Application | Strategic Value |
|---|---|---|---|
| Genome Editing Services | RNP-based CRISPR-Cas9 | "Scarless" gene KO & Knock-in | High-efficiency editing; no DNA integration |
| Pathway Optimization | Competitive pathway elimination | Organic acid & Biofuel production | Directs carbon flow away from byproducts |
| Protein Expression | Secretion & folding engineering | Recombinant enzymes & Antibodies | Achieves high extracellular titers |
| Strain Development | High-throughput phenotyping | Industrial chassis development | Identifies top-performing fungal leads |
| Multi-Gene Knockout | Multiplexed genomic deletion | "Clean-background" host prep | Reduces metabolic load & genetic complexity |
| Assay & Modeling | Quantitative molecular analytics | Diagnostics & Bioprocess modeling | Predictive insights for process control |
1. Target Mapping
2. System Design
3. Strain Transformation
4. Bioprocess Validation
Utilizing genome-scale metabolic models (GEMs) to identify rate-limiting steps and carbon-sink side reactions for optimization.
Technical project feasibility study and Mutual NDA signing.
Customizing gRNAs and donor DNA templates for RNP-based CRISPR-Cas9 editing, including promoter swaps and energy-balancing overexpressions.
Simulation of carbon redirection to ensure optimal growth-production balance.
High-efficiency protoplast transformation using optimized chemical or physical delivery methods for industrial Aspergillus niger strains.
Rapid identification of top-performing clones via micro-scale fermentation and metabolic profiling.
Testing engineered strains in 5L-50L bioreactors to confirm stability, titer, and yield under commercial-mimicking conditions.
Final delivery of optimized industrial strains and comprehensive characterization dossiers.
We benchmark our metabolic solutions against landmark research to deliver high-performance industrial cell factories.
Transitioning to renewable feedstocks is critical. Technical benchmarks successfully implemented an RNP-based CRISPR-Cas9 system in A. niger to produce succinic acid. By knocking out competitive pathways (gluconic and oxalic acid) and overexpressing dicarboxylic transporters, researchers achieved a titer of 17 g/L using renewable biomass like sugar beet pulp.
(Reference: Biotechnology for Biofuels, 2020)
Maximizing enzyme activity requires an optimized intracellular environment. Industrial projects have utilized CRISPR-Cas9 to tune cellular redox state by overexpressing NADH kinase (nadhk). By improving the NAD+/NADH ratio and knocking out negative regulators, technical teams significantly enhanced glucoamylase activity and substrate conversion rates.
(Reference: JIMB, 2022)
The physical structure of a fungus directly impacts industrial utility. Recent benchmarks in food biotechnology utilized CRISPR/Cas9 to target morphology-related genes (e.g., pkaA). By engineering a dispersed mycelium morphology, researchers reduced broth viscosity and improved nutrient penetration, dramatically increasing the yield of sustainable mycoprotein.
(Reference: Bioresource Technology, 2025)
Ready to leverage advanced genomic rewiring for your industrial fungal production?
Contact Us1. What is the advantage of RNP delivery over traditional plasmid CRISPR?
RNP delivery involves pre-assembled protein-RNA complexes. Because no DNA encoding Cas9 is integrated, there is no risk of ongoing off-target mutations, and the final strain is "cleaner" for regulatory purposes.
2. How does morphology engineering improve enzyme production yields?
By changing growth from thick pellets to dispersed mycelia, we reduce fermentation broth viscosity. This improves oxygen transfer and nutrient uptake, often leading to significantly higher production titers.
3. Do you provide services for utilizing non-traditional carbon sources?
Absolutely. We specialize in engineering pathways for the utilization of xylose, arabinose, and other sugars found in lignocellulosic biomass to support a sustainable bioeconomy.
4. How do you ensure the genetic stability of highly engineered strains?
We perform multi-generation stability testing and utilize site-specific integration into "safe harbor" loci to ensure that your metabolic modifications remain intact during industrial expansion.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.